Groupama Asset Managment grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 14.9% in the 3rd quarter, Holdings Channel.com reports. The fund owned 141,841 shares of the healthcare conglomerate’s stock after acquiring an additional 18,351 shares during the period. UnitedHealth Group comprises about 1.6% of Groupama Asset Managment’s holdings, making the stock its 18th largest position. Groupama Asset Managment’s holdings in UnitedHealth Group were worth $82,932,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Sequoia Financial Advisors LLC increased its holdings in UnitedHealth Group by 7.2% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 21,970 shares of the healthcare conglomerate’s stock worth $11,188,000 after buying an additional 1,472 shares in the last quarter. Roman Butler Fullerton & Co. grew its stake in shares of UnitedHealth Group by 18.4% during the 2nd quarter. Roman Butler Fullerton & Co. now owns 1,156 shares of the healthcare conglomerate’s stock valued at $579,000 after purchasing an additional 180 shares during the period. M&G Plc grew its stake in shares of UnitedHealth Group by 1.4% during the 2nd quarter. M&G Plc now owns 490,926 shares of the healthcare conglomerate’s stock valued at $249,881,000 after purchasing an additional 6,657 shares during the period. Bbjs Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at about $31,000. Finally, Agate Pass Investment Management LLC grew its stake in shares of UnitedHealth Group by 190.9% during the 2nd quarter. Agate Pass Investment Management LLC now owns 1,446 shares of the healthcare conglomerate’s stock valued at $736,000 after purchasing an additional 949 shares during the period. 87.86% of the stock is currently owned by institutional investors.
UnitedHealth Group Price Performance
Shares of UNH stock opened at $549.62 on Monday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The stock has a market capitalization of $505.80 billion, a price-to-earnings ratio of 35.81, a P/E/G ratio of 1.61 and a beta of 0.58. The stock has a fifty day simple moving average of $586.84 and a two-hundred day simple moving average of $559.07. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.
UnitedHealth Group Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.53%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.
Analyst Ratings Changes
A number of research analysts have recently weighed in on UNH shares. KeyCorp started coverage on UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective on the stock. Barclays lifted their price objective on UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a research report on Wednesday, November 27th. UBS Group lowered their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Finally, Truist Financial reissued a “buy” rating and issued a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $626.84.
View Our Latest Stock Analysis on UNH
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- What is Put Option Volume?
- Guidewire Software Provides Long-Awaited Buying Opportunity
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- What’s Behind These 3 Recent Analyst Stock Upgrades?
- Trading Halts Explained
- Fast-Growing Companies That Are Still Undervalued
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.